UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes

Current medical research and opinion, 2014-07, Vol.30 (7), p.1267-1273

2014

Volltextzugriff (PDF)

PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes

Value in health, 2012-06, Vol.15 (4), p.A183-A183

2012

Volltextzugriff (PDF)

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

The New England journal of medicine, 2012-12, Vol.367 (23), p.2204-2213

2012

Volltextzugriff (PDF)

Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

The New England journal of medicine, 2010-07, Vol.363 (4), p.311-320

2010

Volltextzugriff (PDF)

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.3976-3986

2013

Volltextzugriff (PDF)

Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy

Canadian journal of diabetes, 2009, Vol.33 (3), p.242-242

2009

Volltextzugriff (PDF)

Metformin's contraindications should be contraindicated

Canadian Medical Association journal (CMAJ), 2005-08, Vol.173 (5), p.502

2005

Volltextzugriff (PDF)

NIDDM in the elderly

Diabetes care, 1996-12, Vol.19 (12), p.1320

1996

Volltextzugriff (PDF)

Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes

Diabetes care, 1998-10, Vol.21 (10), p.1627

1998

Volltextzugriff (PDF)

Effective Exercise Modality to Reduce Insulin Resistance in Women With Type 2 Diabetes

Diabetes care, 2003-11, Vol.26 (11), p.2977-2982

2003

Volltextzugriff (PDF)

The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study

Diabetes technology & therapeutics, 2016-01, Vol.18 (1), p.22

2016

Volltextzugriff (PDF)

Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes

Diabetes care, 2003-10, Vol.26 (10), p.2835-2841

2003

Volltextzugriff (PDF)

Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes

Diabetes (New York, N.Y.), 1998-12, Vol.47 (12), p.1915

1998

Volltextzugriff (PDF)

Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial

Diabetes technology & therapeutics, 2012-02, Vol.14 (2), p.143

2012

Volltextzugriff (PDF)

OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods

Diabetes technology & therapeutics, 2014-07, Vol.16 (7), p.414

2014

Volltextzugriff (PDF)

Post-transplant diabetic ketoacidosis : A possible consequence of immunosuppression with calcineurin inhibiting agents : A case series

Transplant international, 2000, Vol.13 (1), p.69-72

2000

Volltextzugriff (PDF)

Significance of GAD positivity in elderly patients with diabetes

Diabetic medicine, 2000-03, Vol.17 (3), p.247-248

2000

Volltextzugriff (PDF)

Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin

Diabetes care, 1998-01, Vol.21 (1), p.93

1998

Volltextzugriff (PDF)

Diabetes screening in Canada (DIASCAN) Study : Prevalence of undiagnosed diabetes and glucose intolerance in family physician offices

Diabetes care, 2001-06, Vol.24 (6), p.1038-1043

2001

Volltextzugriff (PDF)

Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study

Canadian respiratory journal, 2008-09, Vol.15 (6), p.291-294

2008

Volltextzugriff (PDF)

Diabetes teaching—outcome analysis

Patient education and counseling, 1996-10, Vol.29 (1), p.59-65

1996

Volltextzugriff (PDF)

Implementation of treatment protocols in the Diabetes Control and Complications Trial

Diabetes care, 1995-03, Vol.18 (3), p.361

1995

Volltextzugriff (PDF)

PSS16 CHARACTERIZING FUNCTIONAL LIMITATIONS FOR ADULTS WITH DIABETIC RETINOPATHY

Value in health, 2009, Vol.12 (3), p.A77-A77

2009

Volltextzugriff (PDF)

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

Kidney international, 1996-11, Vol.50 (5), p.1651-1658

1996

Volltextzugriff (PDF)

Syndrome of inappropriate secretion of antidiuretic hormone in association with chlorpromazine ingestion

Canadian journal of psychiatry, 1983-10, Vol.28 (6), p.487

1983

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(92)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(48)
Humans
(47)
Female
(40)
Male
(39)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Adult
(26)
Middle Aged
(23)
Endocrinology & Metabolism
(21)
Aged
(15)
Diabetes
(15)
Pharmacology. Drug Treatments
(13)
Adolescent
(12)
Diabetes Mellitus, Type 2 - Drug Therapy
(12)
Diabetes Mellitus, Type 1 - Drug Therapy
(10)
Diabetes Mellitus, Type 2 - Blood
(10)
Diabetes. Impaired Glucose Tolerance
(10)
Endocrine Pancreas. Apud Cells
(10)
Endocrinopathies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes

PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy

Metformin's contraindications should be contraindicated

NIDDM in the elderly

Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes

Effective Exercise Modality to Reduce Insulin Resistance in Women With Type 2 Diabetes

The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study

Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes

Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes

Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial

OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods

Post-transplant diabetic ketoacidosis : A possible consequence of immunosuppression with calcineurin inhibiting agents : A case series

Significance of GAD positivity in elderly patients with diabetes

Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin

Diabetes screening in Canada (DIASCAN) Study : Prevalence of undiagnosed diabetes and glucose intolerance in family physician offices

Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study

Diabetes teaching—outcome analysis

Implementation of treatment protocols in the Diabetes Control and Complications Trial

PSS16 CHARACTERIZING FUNCTIONAL LIMITATIONS FOR ADULTS WITH DIABETIC RETINOPATHY

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

Syndrome of inappropriate secretion of antidiuretic hormone in association with chlorpromazine ingestion

Suchergebnisse filtern